1. Home
  2. ACOG vs OPXS Comparison

ACOG vs OPXS Comparison

Compare ACOG & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • OPXS
  • Stock Information
  • Founded
  • ACOG 2000
  • OPXS 1987
  • Country
  • ACOG Canada
  • OPXS United States
  • Employees
  • ACOG N/A
  • OPXS N/A
  • Industry
  • ACOG
  • OPXS Electronic Components
  • Sector
  • ACOG
  • OPXS Technology
  • Exchange
  • ACOG Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • ACOG 80.3M
  • OPXS 72.2M
  • IPO Year
  • ACOG N/A
  • OPXS N/A
  • Fundamental
  • Price
  • ACOG $10.80
  • OPXS $11.45
  • Analyst Decision
  • ACOG Strong Buy
  • OPXS
  • Analyst Count
  • ACOG 1
  • OPXS 0
  • Target Price
  • ACOG $20.00
  • OPXS N/A
  • AVG Volume (30 Days)
  • ACOG 67.4K
  • OPXS 81.9K
  • Earning Date
  • ACOG 08-14-2025
  • OPXS 08-12-2025
  • Dividend Yield
  • ACOG N/A
  • OPXS N/A
  • EPS Growth
  • ACOG N/A
  • OPXS 36.84
  • EPS
  • ACOG N/A
  • OPXS 0.71
  • Revenue
  • ACOG $2,928,654.00
  • OPXS $37,431,000.00
  • Revenue This Year
  • ACOG N/A
  • OPXS N/A
  • Revenue Next Year
  • ACOG N/A
  • OPXS N/A
  • P/E Ratio
  • ACOG N/A
  • OPXS $16.08
  • Revenue Growth
  • ACOG N/A
  • OPXS 21.76
  • 52 Week Low
  • ACOG $3.75
  • OPXS $5.36
  • 52 Week High
  • ACOG $11.54
  • OPXS $13.00
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • OPXS 68.58
  • Support Level
  • ACOG N/A
  • OPXS $10.03
  • Resistance Level
  • ACOG N/A
  • OPXS $13.00
  • Average True Range (ATR)
  • ACOG 0.00
  • OPXS 0.80
  • MACD
  • ACOG 0.00
  • OPXS 0.08
  • Stochastic Oscillator
  • ACOG 0.00
  • OPXS 78.10

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: